Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double Protease Inhibitor to Darunavir Switch Study
NCT00531557Phase 4Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Sep 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of darunavir in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Primary endpoint: Proportion of subjects maintaining viral suppression (< 50 copies/mL) at 48 weeks. Started Sep 2007; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00531557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531557.